YOLFTbeta
Oxurion NV

Oxurion NV

OXUR · BR · Healthcare / Biotechnology

0.0006EUR-0.00 (-25.00%)

Price History

Full chart

Market Stats

Previous Close0.0008
Open0.0008
Day Range0.0006 – 0.001
52-Week Range0.001 – 0.0186
Volume5.33M
Market Cap176.45K
P/E (TTM)0.01
Forward P/E4.59
EPS0.16
Dividend Yield0.00%
Beta-0.09
50-Day Avg0.0024
200-Day Avg0.0042

About

Oxurion NV, a biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium. The company is developing ophthalmic treatments to preserve vision for patients geographic atrophy and wet age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Pascal Ghoson
  • Employees26
  • HeadquartersGaston Geenslaan 1, Leuven, Belgium, 3001, Belgium
  • Websitehttps://www.oxurion.com

Leadership

  • Mr. Pascal GhosonCEO, CFO & Executive Director · b. 1989

Financials

Income Statement

Currency: EUR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.24M1.25M30.42M4.21M6.17M2.48M75.08M112.78M13.78M11.20M7.10M5.81M5.32M3.95M2.08M1.13M595.00K263.00K3.00K555.00K
Growth (%)--61.39%+2329.79%-86.15%+46.57%-59.90%+2932.43%+50.21%-87.79%-18.71%-36.56%-18.22%-8.43%-25.83%-47.34%-45.72%-47.25%-55.80%-98.86%+18400.00%
Cost of Revenue1.21M168.00K2.75M270.00K540.00K216.00K3.15M6.38M4.60M3.23M6.88M2.58M3.35M5.03M1.66M1.29M866.00K159.00K43.00K68.00K
Gross Profit2.03M1.08M27.67M3.94M5.63M2.26M71.94M106.40M9.18M7.97M224.00K3.23M1.97M-1.09M419.00K-161.00K-271.00K104.00K-40.00K487.00K
Gross Margin62.60%86.58%90.97%93.59%91.26%91.28%95.81%94.34%66.61%71.16%3.15%55.61%36.94%-27.52%20.16%-14.27%-45.55%39.54%-1333.33%87.75%
Operating Expense-8.40M-16.33M17.09M-11.04M-9.03M27.03M42.84M80.89M61.89M46.88M34.47M32.71M41.21M36.82M30.17M28.53M22.68M12.21M-422.00K4.12M
Operating Income10.43M17.42M10.59M14.99M14.66M-24.77M29.10M25.51M-52.71M-38.92M-34.25M-29.48M-39.24M-37.91M-29.75M-28.69M-22.95M-12.11M382.00K-3.63M
Operating Margin321.49%1391.13%34.80%355.73%237.41%-1000.48%38.76%22.62%-382.65%-347.54%-482.09%-507.38%-737.61%-960.59%-1431.91%-2543.26%-3856.47%-4604.56%12733.33%-653.87%
EBITDA-8.76M-17.10M12.34M-13.53M-14.23M-21.25M31.12M33.17M-42.81M-29.87M-52.66M26.49M-35.12M-49.26M-27.40M-28.18M-29.96M-16.73M278.00K-3.62M
EBITDA Margin-270.00%-1365.50%40.55%-321.03%-230.51%-858.40%41.44%29.42%-310.77%-266.71%-741.22%455.94%-660.11%-1248.30%-1318.38%-2497.87%-5035.80%-6360.84%9266.67%-652.43%
Net Income-10.13M-15.97M12.10M-14.07M-13.94M-21.64M30.41M26.40M-51.12M-37.88M-60.31M22.79M-38.47M-51.83M-28.01M-29.16M-31.68M-18.97M119.00K-3.73M
Net Income Margin-312.49%-1275.32%39.76%-333.97%-225.78%-873.87%40.51%23.41%-371.04%-338.31%-849.01%392.22%-723.20%-1313.41%-1348.03%-2584.93%-5325.21%-7212.55%3966.67%-671.71%
R&D8.12M17.23M15.71M19.48M18.68M19.68M20.05M35.09M23.86M22.96M24.71M24.01M29.60M23.74M21.58M20.20M15.68M9.99M1.24M1.85M
R&D as % of Total Revenue250.35%1376.36%51.65%462.28%302.51%794.67%26.71%31.11%173.18%205.00%347.86%413.24%556.32%601.57%1038.45%1790.43%2635.97%3797.34%41166.67%332.61%
Interest Expense32.00K321.00K1.75M381.00K206.00K20.00K28.00K26.00K33.00K37.00K36.00K31.00K24.00K55.00K54.00K739.00K1.37M1.97M218.00K9.00K
Interest Expense % of Total Revenue0.99%25.64%5.75%9.04%3.34%0.81%0.04%0.02%0.24%0.33%0.51%0.53%0.45%1.39%2.60%65.51%230.25%748.67%7266.67%1.62%

Balance Sheet

Currency: EUR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets37.33M52.00M67.20M101.22M142.94M129.09M239.17M271.15M220.71M178.95M121.64M150.44M114.86M65.03M34.28M18.88M11.99M6.55M5.70M3.83M
Total Liabilities2.06M3.56M4.81M7.50M4.75M11.06M11.21M12.38M12.70M8.93M11.78M17.08M9.55M11.72M9.24M19.98M16.58M19.74M16.75M16.51M
Total Equity35.28M48.44M62.39M93.72M138.19M118.03M227.97M258.77M208.01M169.94M109.82M132.63M104.89M53.16M25.18M-1.08M-4.58M-13.19M-11.06M-12.89M
Cash32.04M40.11M30.36M75.93M85.87M57.55M139.40M164.57M123.22M93.34M58.25M56.17M64.65M42.49M24.51M9.74M3.50M1.62M455.00K430.00K
Total Debt-------------2.23M1.10M12.10M8.02M12.33M11.33M11.44M
Net Debt-32.04M-40.11M-30.36M-75.93M-85.87M-57.55M-139.40M-164.57M-123.22M-93.34M-58.25M-56.17M-64.65M-40.26M-23.41M2.36M4.52M10.71M10.87M11.01M

Cash Flow

Currency: EUR2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-8.42M-14.80M11.96M-12.10M-16.84M-19.56M27.79M25.71M-46.58M-27.79M-20.31M26.30M-31.12M-31.10M-27.10M-27.16M-20.02M-9.77M-2.07M-1.71M
Investing Cash Flow499.00K-5.26M-22.51M12.68M-30.61M-10.34M-22.75M-3.05M4.45M-2.82M-15.13M-27.56M29.11M10.01M10.07M484.00K106.00K72.00K84.00K-270.00K
Financing Cash Flow31.37M28.25M1.25M44.75M57.35M510.00K77.17M2.95M-11.00K-8.00K-6.00K9.99M84.00K-843.00K-919.00K11.78M13.00M7.82M815.00K1.95M
Capital Expenditure162.00K866.00K2.62M15.80M8.76M12.17M37.20M2.15M571.00K354.00K572.00K246.00K195.00K133.00K119.00K32.00K59.00K1.00K00
Free Cash Flow-8.58M-15.66M9.34M-27.90M-25.61M-31.74M-9.41M23.55M-47.15M-28.15M-20.88M26.05M-31.31M-31.23M-27.22M-27.19M-20.07M-9.77M-2.07M-1.71M
FCF to OCF101.92%105.85%78.10%230.59%152.03%162.22%-33.87%91.62%101.23%101.27%102.82%99.06%100.63%100.43%100.44%100.12%100.29%100.01%100.00%100.00%

Earnings

Report DateMar 17, 2014Aug 28, 2014Mar 12, 2015Aug 26, 2015Mar 18, 2016Aug 25, 2016Oct 20, 2016Mar 16, 2017May 11, 2017Sep 7, 2017Oct 20, 2017Mar 16, 2018May 9, 2018Sep 6, 2018Oct 19, 2018Mar 7, 2019May 8, 2019Sep 5, 2019Oct 18, 2019Mar 12, 2020May 7, 2020Sep 17, 2020Oct 15, 2020Mar 17, 2021May 6, 2021Sep 9, 2021Oct 14, 2021Mar 25, 2022May 12, 2022Sep 7, 2022Oct 21, 2022Mar 24, 2023May 4, 2023Sep 29, 2023Oct 20, 2023Apr 15, 2024Sep 30, 2024Nov 29, 2024Mar 31, 2025Apr 11, 2025Sep 30, 2025Nov 28, 2025
EPS Estimate-0.70-0.70-0.600.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.450.00-0.410.00-0.520.00-0.36-0.21-1700.00-0.18-0.12-0.10-0.08-0.08-0.07-0.07-0.060.000.000.000.000.000.00
EPS Actual0.000.000.000.000.000.000.000.000.00-0.420.001.020.00-0.390.00-1.010.00-0.870.00-0.490.00-0.340.00-0.410.00-0.42-2100.00-1800.00-0.18-0.320.00-0.200.000.000.000.000.000.000.000.00-0.240.00
Surprise100.00%100.00%100.00%-----------------8.89%-17.07%-21.15%--16.67%-999900.00%-5.88%0.00%-166.67%100.00%-150.00%100.00%100.00%100.00%100.00%------
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours---After-hours-Pre-market-After-hoursPre-marketAfter-hours-Pre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hours-After-hours-Pre-market-After-hours-After-hours-After-hours------

Key Statistics & Ratios

Market Cap176.45K
Enterprise Value11.24M
Trailing P/E0.01
Forward P/E4.59
Price / Sales0.15
Price / Book6.25
EPS0.16
Book Value-0.206
Revenue (TTM)1.15M
Gross Profit (TTM)1.14M
EBITDA-2.22M
Profit Margin0.00%
Operating Margin-127.75%
Return on Equity-694.15%
Return on Assets-33.45%
Shares Outstanding176.45M
Shares Float78.71M
Beta-0.09
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 3, 20241:10000